vimarsana.com

Latest Breaking News On - Motiva implant - Page 1 : vimarsana.com

Establishment Labs Notes Presentation of 4-Year Results from Motiva U S IDE Study at The Aesthetic Meeting 2024

Establishment Labs Holdings Inc. , a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the.

Establishment Labs Holdings Inc (NASDAQ:ESTA) Q4 2023 Earnings Call Transcript

Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2023 Earnings Call Transcript February 28, 2024 Establishment Labs Holdings Inc. beats earnings expectations. Reported EPS is $-0.79, expectations were $-0.95. ESTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Welcome to […]

Establishment Labs (ESTA) Submits Module Four to U S FDA for Premarket Approval of Motiva, Reports Q4

Establishment Labs (ESTA) Submits Module Four to U S FDA for Premarket Approval of Motiva, Reports Q4
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022

Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Establishment Labs Holdings (ESTA) Announces Preliminary Unaudited Revenue for Fourth Quarter

Establishment Labs Holdings (ESTA) Announces Preliminary Unaudited Revenue for Fourth Quarter
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.